ATOMIC Trial Supports Atezolizumab Plus FOLFOX as the New Standard in dMMR Stage Colon Cancer

1 month ago 16

Prof David Kerr reviews the ATOMIC trial, highlighting the potential of atezolizumab plus FOLFOX as a new standard for dMMR stage III colon cancer.

1. Homepage
2. Colon Cancer
3. ATOMIC Trial Supports Atezolizumab Plus FOLFOX as the New Standard in dMMR Stage Colon Cancer